Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Updates present: a status notice about funding-related delays and open NIH Clinical Center with links for more details, and a version bump to v3.2.0. This shifts core information and versioning; no other functional changes are evident.
    Difference
    4%
    Check dated 2025-10-05T14:28:55.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Added a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.
    Difference
    0.4%
    Check dated 2025-09-28T09:46:35.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed. No changes to core content, pricing, stock availability, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T00:18:30.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T21:11:07.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated to include specific information about drug safety and counterfeit drugs, along with the addition of a facility name and location in St. Louis, Missouri. Notably, references to certain diseases have been removed, including Acute Graft Versus Host Disease and Acute Non Lymphoblastic Leukemia.
    Difference
    3%
    Check dated 2025-08-30T15:35:59.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.8%
    Check dated 2025-08-23T14:12:15.000Z thumbnail image

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.